130 related articles for article (PubMed ID: 1849032)
1. Inhibition by 1,25 dihydroxyvitamin D3 of chemically induced erythroid differentiation of K562 leukemia cells.
Moore DC; Carter DL; Bhandal AK; Studzinski GP
Blood; 1991 Apr; 77(7):1452-61. PubMed ID: 1849032
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by 1,25 dihydroxyvitamin D3 of c-myc down-regulation and DNA fragmentation in cytosine arabinoside-induced erythroid differentiation of K562 cells.
Moore DC; Carter DL; Studzinski GP
J Cell Physiol; 1992 Jun; 151(3):539-48. PubMed ID: 1295901
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 receptor RNA: expression in hematopoietic cells.
Kizaki M; Norman AW; Bishop JE; Lin CW; Karmakar A; Koeffler HP
Blood; 1991 Mar; 77(6):1238-47. PubMed ID: 1705836
[TBL] [Abstract][Full Text] [Related]
4. Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy-pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses.
Norman AW; Okamura WH; Farach-Carson MC; Allewaert K; Branisteanu D; Nemere I; Muralidharan KR; Bouillon R
J Biol Chem; 1993 Jul; 268(19):13811-9. PubMed ID: 8390978
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
Nagasaki T; Hino M; Inaba M; Nishizawa Y; Morii H; Otani S
Arch Biochem Biophys; 1997 Jul; 343(2):181-7. PubMed ID: 9224728
[TBL] [Abstract][Full Text] [Related]
6. Monocytic differentiation of acute promyelocytic leukemia cells in response to 1,25-dihydroxyvitamin D3 is independent of nuclear receptor binding.
Bhatia M; Kirkland JB; Meckling-Gill KA
J Biol Chem; 1995 Jul; 270(27):15962-5. PubMed ID: 7608152
[TBL] [Abstract][Full Text] [Related]
7. Dibutyryl cAMP enhances the effect of 1,25-dihydroxyvitamin D3 on a human promyelocytic leukemia cell, HL-60, at both the receptor and the postreceptor steps.
Inaba M; Okuno S; Koyama H; Nishizawa Y; Morii H
Arch Biochem Biophys; 1992 Feb; 293(1):181-6. PubMed ID: 1309983
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
Reinhardt TA; Horst RL
Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
[TBL] [Abstract][Full Text] [Related]
9. 1,25(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25(OH)2D3 receptor in HL-60 cells and related subclones.
Taoka T; Collins ED; Irino S; Norman AW
Mol Cell Endocrinol; 1993 Sep; 95(1-2):51-7. PubMed ID: 8243807
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1).
Muto A; Kizaki M; Yamato K; Kawai Y; Kamata-Matsushita M; Ueno H; Ohguchi M; Nishihara T; Koeffler HP; Ikeda Y
Blood; 1999 Apr; 93(7):2225-33. PubMed ID: 10090931
[TBL] [Abstract][Full Text] [Related]
11. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.
Koizumi T; Nakao Y; Ishizuka S; Oshida J; Hara N; Ikekawa N; Fijita T
Arch Biochem Biophys; 1990 Feb; 276(2):310-6. PubMed ID: 2407190
[TBL] [Abstract][Full Text] [Related]
12. Modulation by cAMP of 1alpha,25-dihydroxyvitamin D3 sensitivity of murine erythroleukemia cells.
Waki M; Inaba M; Hiura Y; Nagasaki T; Imanishi Y; Ishimura E; Otani S; Nishizawa Y
Arch Biochem Biophys; 2001 Jul; 391(2):265-70. PubMed ID: 11437358
[TBL] [Abstract][Full Text] [Related]
13. 1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro.
Elstner E; Lee YY; Hashiya M; Pakkala S; Binderup L; Norman AW; Okamura WH; Koeffler HP
Blood; 1994 Sep; 84(6):1960-7. PubMed ID: 8080998
[TBL] [Abstract][Full Text] [Related]
14. Potentiation by 1-alpha,25-dihydroxyvitamin D3 of cytotoxicity to HL-60 cells produced by cytarabine and hydroxyurea.
Studzinski GP; Bhandal AK; Brelvi ZS
J Natl Cancer Inst; 1986 Apr; 76(4):641-8. PubMed ID: 3457201
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by 1 alpha,25-dihydroxyvitamin D3 of dimethyl sulfoxide-induced differentiation of Friend erythroleukemia cells.
Suda S; Enomoto S; Abe E; Suda T
Biochem Biophys Res Commun; 1984 Mar; 119(2):807-13. PubMed ID: 6324774
[TBL] [Abstract][Full Text] [Related]
16. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages.
Kreutz M; Andreesen R; Krause SW; Szabo A; Ritz E; Reichel H
Blood; 1993 Aug; 82(4):1300-7. PubMed ID: 8394753
[TBL] [Abstract][Full Text] [Related]
17. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
Imai Y; Pike JW; Koeffler HP
Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
[TBL] [Abstract][Full Text] [Related]
18. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
Inaba M; Okuno S; Nishizawa Y; Yukioka K; Otani S; Matsui-Yuasa I; Morisawa S; DeLuca HF; Morii H
Arch Biochem Biophys; 1987 Nov; 258(2):421-5. PubMed ID: 2823715
[TBL] [Abstract][Full Text] [Related]
19. Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes.
Matsumoto K; Azuma Y; Kiyoki M; Okumura H; Hashimoto K; Yoshikawa K
Biochim Biophys Acta; 1991 May; 1092(3):311-8. PubMed ID: 1646640
[TBL] [Abstract][Full Text] [Related]
20. Differentiation-related regulation of 1,25-dihydroxyvitamin D3 receptor mRNA in human leukaemia cells HL-60.
Pan P; Reddy K; Lee S; Studzinski GP
Cell Prolif; 1991 Mar; 24(2):159-70. PubMed ID: 1849022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]